Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs Sevoflurane in Colon Cancer Surgery
NCT04259398Active, not recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2020
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of propofol injection (veterinary) in colon cancer, sponsored by Seoul National University Hospital. Primary endpoint: Overall Survival at 5 years. Started Feb 2020; status: active, not recruiting.
02
Drugs
propofol injection (veterinary)
03
Conditions
colon cancer
Beyond the preview
Go deeper on NCT04259398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04259398.